The psychedelic medicine conference circuit is expanding as the field moves from clinical research towards treatment, regulation and healthcare delivery. Across the US, Europe, Australia and other research centres, conferences and professional events are bringing together researchers, clinicians, therapists, regulators, investors and healthcare operators to examine different parts of the emerging sector. This calendar tracks […]
Already subscribed? Log in
Running from 2–8 November, the international event features online discussions, community gatherings and a keynote from Atai co-founder Christian Angermayer following Eli Lilly's acquisition of AtaiBeckley. Global Psychedelic...
Academic researchers, clinicians, healthcare entrepreneurs and investors feature in the first announcement for Melbourne’s psychedelic medicine symposium, with major keynote and sponsor announcements to follow. The PRS27 Psychedelic...
The three-day conference, hosted by entrepreneur Dave Asprey, brings together researchers, clinicians and business leaders to discuss psychedelic therapies, neuroscience and emerging approaches to mental healthcare. Researchers, clinicians...
With six months to go until the inaugural PRS27 Psychedelic Roundtable Symposium, Psychedelics.media has announced that early bird tickets are now on sale for what is being positioned...
Psychedelics.media delivers trusted news, intelligence, and insights for the global psychedelic medicine industry.
